January 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03
September 30, 2017 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This FOA is a Broad Agency Announcement (BAA) open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Preliminary proposals (pre-proposals) are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1


Rolling All Ranks Non-federal Health Policy

Robert Wood Johnson Foundation
Evidence for Action: Investigator-Initiated Research to Build a Culture of Health - Open Call for Proposals

To support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships. Of special interest is research examining the health impacts of programmatic or policy interventions that address factors outside the domain of health care services or public health practice.
Due Dates: Applications accepted on a rolling basis, there is no deadline for submission.  Applicants notified w/in 6-8 weeks of Letter of Intent.  Full proposals are due 2 months after invitation.
Amount & Project Period: No explicit range for allowable budget requests - 3  years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Call for Proposals | Apply Online



December 21, 1:00pm - EST Postdocs Non-federal Career Development

AACR-OMF Ocular Melanoma Fellowship

To encourage and support a postdoctoral or clinical research fellow to conduct ocular/uveal melanoma research.  Research proposed must be translational or clinical in nature and must have direct, primary applicability and relevance to ocular/uveal melanoma.
Due Dates: Dec. 19 (OSR) Ι Dec. 21, 1:00pm (EST) (Sponsor)
Amount & Project Period: $110,000 - 2 years
Eligibility: Applicants must hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or the equivalent;
Applicants must have completed most recent doctoral degree w/in past five years; and
Applicants must work under the auspices of a mentor
See Guidelines for additional requirements.
Contact: Office of Sponsored Research (x6804)
Links: Overview
Guidelines
proposalCENTRAL (Submission Site)




December 21, 1:00pm - EST Junior Faculty Non-federal Career Development

AACR-BCRF Career Development Awards for Translational Breast Cancer Research

To promote and support innovative research designed to accelerate the discovery, development, and application of new agents to treat breast cancer and/or for pre-clinical research with direct therapeutic intent.
Due Dates: Dec. 19 (OSR) Ι Dec. 21, 1:00pm (EST) (Sponsor)
Amount & Project Period: $150,000 - 2 years
Eligibility: Applicants must hold a faculty position w/title of asst. professor, instructor, research asst. professor, or equiv. and have completed most recent doctoral degree w/in past 11 years;
If eligibility based on future position, position must be confirmed at the time of application, and CANNOT be contingent upon receiving this grant.
See Guidelines for additional requirements
Contact: Office of Sponsored Research (x6804)
Links: Overview
Guidelines
proposalCENTRAL (Submission Site)
P01 NCI

December 27 (LOI) All Ranks Federal Multiple Projects Research Programs

National Cancer Institute Program Project Applications

This FOA invites grant applications for investigator-initiated Program Projects (P01) in any area of cancer research. P01 grants support integrated, multi-project research programs involving a number of independent investigators who share knowledge and common resources while working towards a unifying overall scientific goal.
Due Dates: Dec. 27 (Letter of Intent)
Jan. 23 (OSR) Ι Jan. 25 (Sponsor)
Additional Due Dates: Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Note:  Applicants requesting $500,000 or more in direct costs in any year (excl. consortium F&A) must contact a Scientific/ Research Contact at least 6 weeks before submitting application and follow Policy on Acceptance for Review of Unsolicited Applications that Request $500,000 or More in Direct Costs as described in SF424 (R&R) Application Guide.
Eligibility: All Ranks - The NCI encourages P01 applicants to take advantage of the multiple PD/PI option. Use of this option allows, for example, designation of any (or all) of leaders of individual projects or cores as a PD/PI of overall application.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-457
R25 NIH

NEW
December 27 (LOI) All Ranks Federal Cancer Research Education

National Cancer Institute Youth Enjoy Science (YES) Research Education Program

This FOA supports creative educational activities with a primary focus on Research Experiences, Curriculum or Methods Development and Outreach.  The NCI YES Program will support efforts to create and maintain an institutional program to engage grades 6-12 and/or undergraduate students from underrepresented populations in cutting edge cancer research experiences.  Proposed programs may also provide research experiences for grade 6-12 teachers and undergraduate faculty members who serve underrepresented student populations.
Due Dates: Dec. 27 (Letter of Intent)
Jan. 23 (OSR) Ι Jan. 25 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: $500,000 (MAX)/yr. (Direct Costs) -5 years
Eligibility: All Ranks - The PD/PI sh/be an established investigator in scientific area in which application is targeted and capable of providing administrative and scientific leadership to development & implementation of proposed program.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-059

December 30 Postdocs Non-federal Travel Support Award

Medicines
2017 Travel Award for Postdocs

Applications are invited for a Travel Award for postdocs to present his/her data, in poster or oral presentation formats, at a scientific conference in 2017.
Due Dates: Dec. 28 (OSR) Ι Dec. 30 (Sponsor)
Amount & Project Period: Est. $825 (US) - (800 Swiss francs)
Eligibility: Postdoctoral fellows involved in evidence-based classical, complementary and integrative medicine research.
Contact: Office of Sponsored Research (x6804)
 Links: Medicines  Ι 2017 Travel Award for Postdocs


January 01 All Ranks Non-federal Liver

Fibrolamellar Cancer Foundation (FCF)
Research Grants

Research must focus on fibrolamellar hepatocellular carcinoma. Studies should be intended to advance knowledge in the areas of FL-CC. Of particular interest are those showing a clear path to clinical trials.
Due Dates: Dec.29 (OSR) Ι Jan. 01 (Sponsor)
Additional Due Date:  July 01
Amount & Project Period: Funding and performance period are variable.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: RFP Ι Apply for a Grant  Ι FCF
R50 NCI

January 03 (LOI) Core Scientists Federal Career Development

NCI Research Specialist (Core-based Scientist) Award

This FOA invites grant applications for the Research Specialist Award in any area of NCI-funded cancer research.  This FOA is specifically for core/shared resource/central scientific support scientists.
Due Dates: January 03 (Letter of Intent)
Applications Due:  Jan. 31 (OSR) Ι Feb. 02 (Sponsor)
Amount & Project Period: The following direct costs may be requested for each of 5 years:
1) Salary support for the Research Specialist commensurate w/the current level of funded effort (at least 6-person months) on NCI-funded research grants; and
2) Travel costs to attend research meetings/conferences not to exceed $2,500 per year
Eligibility: Candidate must have advanced degree in an area of biomedical science or biomedical engineering and have demonstrated research accomplishments in primary discipline.
Candidate must have full-time, non-tenure track position at institution and be supported by at least 6-person month effort on NCI-funded research at the time of submission.
Candidate will be required to commit a minimum of 6-person months (50%) effort on NCI-funded research in order to receive the R50 award.
Candidate may engage in other duties as part of the remaining 6-person month effort not covered by this award.
Candidate must have demonstrated professional accomplishments consonant w/career status, and should have demonstrated cancer research experience in the areas of behavioral, biomedical (basic or clinical), computational or bioengineering research relevant to the NCI mission.
Candidate must have been contributing to the Unit Director's NCI-funded research activities currently being conducted w/in the core/shared resource for at least the last 2 years (since February 2015).
Candidate must not have held or applied for independent investigator grant support (e.g. including but not limited to: R00, R01, R03, R21, R43, R44) w/in the past 5 years.
Eligibility Requirements for the Unit Director:
The Unit Director must be an NCI-funded Principal Investigator (PD/PI) with NCI funding support through September 2019, excluding no cost extensions or supplements.
The Unit Director must be currently supporting the Research Specialist with his/her NCI grant(s) and be committed to both the Research Specialist and the Research Specialist's research.
Only 1 Unit Director may be designated on the application. Applications that list more than 1 Unit Director, or in which the Unit Director does not indicate eligible NCI grant support will not be reviewed.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-050
R50 NCI

January 03 (LOI) Laboratory Scientists Federal Career Development

NCI Research Specialist (Laboratory-based Scientist) Award

This FOA invites grant applications for the Research Specialist Award in any area of NC-funded cancer research.  This FOA is specifically for laboratory-based scientists.
Due Dates: January 03 (Letter of Intent)
Applications Due:  Jan. 31 (OSR) Ι Feb. 02 (Sponsor)
Amount & Project Period: The following direct costs may be requested for each of 5 years:
1) Salary support for the Research Specialist commensurate w/the current level of funded effort (at least 6-person months) on NCI-funded research grants; and
2) Travel costs to attend research meetings/conferences not to exceed $2,500 per year
Eligibility: Candidate must have advanced degree in an area of biomedical science or biomedical engineering and have demonstrated research accomplishments in primary discipline.
Candidate must have full-time, non-tenure track position at institution and be supported by at least 6-person months effort on NCI-funded research at the time of submission.
Candidate will be required to commit a minimum of 6-person months (50%) effort on NCI-funded research in order to receive the R50 award.
Candidate may engage in other duties as part of the remaining 6-person month effort not covered by this award.
Candidate must have demonstrated professional accomplishments consonant w/career status, and should have demonstrated cancer research experience in the areas of behavioral, biomedical (basic or clinical), computational or bioengineering research relevant to the NCI mission.
Candidate must have been contributing to the Unit Director's NCI-funded research for at least the last 2 years (since February 2015). Candidate must not have held or applied for independent investigator grant support (e.g. including but not limited to: R00, R01, R03, R21, R43, R44) w/in the past 5 years.
Eligibility Requirements for the Unit Director:
The Unit Director must be a NCI-funded PD/PI with NCI funding support through September 2019, excluding no cost extensions or supplements.
The Unit Director must be currently supporting the Research Specialist with his/her NCI grant(s) and be committed to both the Research Specialist and the Research Specialist's research.
Only 1 Unit Director may be designated on the application. Applications that list more than 1 Unit Director, or in which the Unit Director does not indicate eligible NCI grant support will not be reviewed.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-049
January 04 (Preliminary Proposal All Ranks Federal Therapeutic Cells

National Science Foundation
Directorate for Engineering Division of Chemical, Bioengineering, Environmental and Transport Systems
Advanced Biomanufacturing of Therapeutic Cells (ABTC)

The overarching goal of this solicitation is to catalyze well-integrated interdisciplinary research to understand, design, and control cell manufacturing systems and processes that will enable reproducible, cost-effective, and high-quality production of cells with predictable performance for the identified therapeutic function.
Due Dates: Jan. 04 (Preliminary Proposal)
Applications Due:  Apr. 15 (OSR) Ι Apr. 17 (Sponsor)
Amount & Project Period: Variable - 4 years
Eligibility: All Ranks - An individual may appear as PI, co-PI, other senior personnel, or consultant on no more than two preliminary proposals or proposals submitted in response to this solicitation.
Contact: Office of Sponsored Research (x6804)
Link: NSF 17-502


January 04 (Preliminary Proposal) All Ranks Federal Data Science

National Science Foundation
Transdisciplinary Research in Principles of Data Science  (TRIPODS)

This initiative aims to bring together the statistics, mathematics, and theoretical computer science communities to develop the theoretical foundations of data science through integrated research and training activities.  Phase I will support the development of small collaborative Institutes.
Due Dates: Jan. 04 (Preliminary Proposal)
Applications Due:  Mar. 13 (OSR) Ι Mar. 15 (Sponsor)
Amount & Project Period: Funding and performance period are variable.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι 16-615


NEW
January 06, 5:00pm All Faculty Moffitt Collaborative Research

Anna D. Valentine USF-Moffitt Cancer Research Award

A collaborative grant competition to support cancer research.
Due Dates: Friday, January 6, 2017,  5:00 pm (Submit as a single pdf to Maureen Ahearn)
Amount & Project Period: $50,000 - 1 year (w/competitive option for 2nd year funding).
Eligibility: Must hold a full-time primary appointment (tenured, tenure-track, or research track at USF Morsani College of Medicine and Moffitt Cancer Center.  Application must include investigators from both institutions.
Contact: Maureen Ahearn (x8824)
Link: RFP 
R01 NHGRI
National Human Genome Research Institute
January 07 All Ranks Federal Genomics/HIV

Genomics of HIV/AIDS Drug Response and Co-Morbidities

The purpose of this funding opportunity announcement is to expand the use of high-throughput genotyping, genomic sequencing, and related genomic technologies, and generate resulting data resources widely available for research use; and to reduce HIV/AIDS-related comorbidities, coinfections, and complications.
Due Dates: Jan. 05 (OSR) Ι Jan. 07 (Sponsor)
Additional Due Dates: May 07 & Sept. 07
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-435
R01 NCI

January 07 All Ranks Federal AIDS and Cancer

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers

To continue advancement of the understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals.
Due Dates: Jan. 04 (OSR) Ι Jan. 07 (Sponsor)
Additional Due Dates: Standard AIDS dates
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-425
Companion FOA: PA-16-426 (R21)
UM1 NCI

January 09 (LOI) All Faculty Ranks Federal Cancer Screening

Population-based Research to Optimize the Screening Process (PROSPR)

This FOA solicits applications for PROSPR UM1 Research Centers to promote research aimed at evaluating and improving the cancer screening process. Overall goal is to enhance understanding of the implementation and effects of screening as practiced in multiple, heterogeneous healthcare environments.
Due Dates: Jan. 09 (Letter of Intent)
Applications due:  Feb. 07 (OSR) Ι Feb. 09 (Sponsor)
Amount & Project Period: $2.5 million/yr.  (Direct Costs) - 5 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-16-016
Companion RFA: RFA-CA-16-017 (U24) Will support a PROSPR Coordinating Center (Restricted to 1 submission per institution)


NEW
January 10, 1:00pm - ET Junior faculty Non-federal Career Development

AACR Career Development Awards for Immuno-oncology Research

These awards promote and support junior faculty to conduct immuno-oncology research.  One grant will be awarded that has particular emphasis on biological mechanisms underlying checkpoint inhibitor resistance and/or approaches to overcome this resistance.  Research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to immuno-oncology.
Due Dates: Jan. 06 (OSR) Ι Jan. 10, 1:00pm (EST) (Sponsor)
Amount & Project Period: $200,000 - 2 years
Eligibility: Hold a faculty position w/title of asst. professor, instructor, research asst. professor, or equiv. If eligibility is based on a future position, position must be confirmed at the time of application, and CANNOT be contingent upon receiving this grant;
Completed most recent doctoral degree w/in past 11 years (cannot have been conferred before 7/2/2006);
ACR membership is required.
Contact: Office of Sponsored Research (x6804)
Links: Guidelines
proposalCENTRAL (Submission Site)
NEW
January 10, 1:00pm - ET Postdocs Non-federal Career Development

AACR Clinical and Translational Cancer Research Fellowship

To encourage and support a postdoctoral or clinical research fellow to conduct clinical and/or translational cancer research and to establish a successful career path in this field. The research proposed for funding may be translational or clinical in nature. 
Due Dates: Jan. 06 (OSR) Ι Jan. 10, 1:00pm (EST) (Sponsor)
Amount & Project Period: $110,000 - 2 years
Eligibility: Hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or equiv;
Have completed most recent doctoral degree w/in past 5 years (i.e., degree cannot have been conferred before July 2, 2012; AACR membership is required.
Contact: Office of Sponsored Research (x6804)
Links: Guidelines Ι proposalCENTRAL (Submission Site)  
NEW
January 10, 1:00pm - ET Postdocs Non-federal Career Development

AACR Fellowships in Lung Cancer Research

Research projects may be basic, translational, clinical, or epidemiological in nature, and must have direct applicability and relevance to lung cancer.
Due Dates: Jan. 06 (OSR) Ι Jan. 10, 1:00pm (EST) (Sponsor)
Amount & Project Period: $110,000 - 2 years
Eligibility: Hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or equiv;
Have completed most recent doctoral degree w/in past 5 years (i.e., degree cannot have been conferred before July 2, 2012; AACR membership is required.
Contact: Office of Sponsored Research (x6804)
Links: Guidelines Ι proposalCENTRAL (Submission Site)



NEW
January 10, 1:00pm - ET Postdocs Non-federal Career Development

AACR-Incyte Leukemia Research Fellowship

Research projects may be basic, clinical, translational, or epidemiological in nature and must have direct applicability and relevance to leukemia research.
Due Dates: Jan. 06 (OSR) Ι Jan. 10, 1:00pm (EST) (Sponsor)
Amount & Project Period: $110,000 - 2 years
Eligibility: Hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or equiv;
Have completed most recent doctoral degree w/in past 5 years (i.e., degree cannot have been conferred before July 2, 2012; AACR membership is required.
Contact: Office of Sponsored Research (x6804)
Links: Guidelines Ι proposalCENTRAL (Submission Site)




NEW
January 11, 1:00pm, EST See Below Non-federal Career Development

AACR and Debbie's Dream Foundation

Due Dates: Jan. 09 (OSR) Ι Jan. 11, 1:00pm, EST (Sponsor)
Contact: Office of Sponsored Research (x6804)
Link: proposalCENTRAL (Submission Site & location of Guidelines)

Career Development Award for Gastric Cancer Research

This initiative represents a joint effort to encourage and support junior faculty to conduct gastric cancer research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to gastric cancer. Projects may focus on any form of gastric cancer.
Amount & Project Period: $200,000 - 2 years
Eligibility: Must Hold a faculty position w/title of assistant professor, instructor, research assistant professor, or equiv. and have independent laboratory space as confirmed by institution;
Must have completed most recent doctoral degree w/in past 11 years (i.e., degree cannot have been conferred before July 2, 2006;
No citizenship requirements, but applicant who is not a U.S. citizen or permanent resident must assure that visa status will provide sufficient time to complete project and grant term w/in the U.S.;
AACR membership is required.
NEW

Gastric Cancer Research Fellowships

This initiative represents a joint effort to encourage and support postdoctoral or clinical research fellows to conduct gastric cancer research.  Research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to gastric cancer.  Projects may focus on any form of gastric cancer.
Amount & Project Period: $50,000 - 1 year
Eligibility: Must hold a mentored research position w/title of postdoctoral fellow, clinical research fellow, or equiv.;
Must have completed most recent doctoral degree w/in past five years (i.e., degree cannot have been conferred before July 2, 2012;
No citizenship requirements, but applicant who is not a U.S. citizen or permanent resident must assure that visa status will provide sufficient time to complete project and grant term w/in the U.S.
AACR membership is required




NEW
January 12, Noon, ET Junior Faculty Non-federal Research Grants

Innovative Research Grants 2017

The SU2C Innovative Research Grants (IRGs) are an effort to support the next generation of extraordinary leaders in their quest to conquer cancer.  The IRGs will fund novel, high-risk, high-reward immuno-oncology research proposals. Proposals may focus on any discipline within basic, translational, or clinical cancer research.
Due Dates: Jan. 10 (OSR) Ι Jan. 12 (Sponsor)
Amount & Project Period: $750,000 - 3 years
Eligibility: Tenure-track (or equiv.) investigators currently in first independent position, appointed no more than 7 years ago (i.e., on or after May 30, 2010);
Applicants must be affiliated with an academic, medical, or research institution w/in U.S. There are no citizenship or residency status restrictions.
Contact: Office of Sponsored Research (x6804)
Links: Guidelines Ι proposalCENTRAL  (Submission Site)


NEW
January 12 All Ranks Non-federal Non Small-cell Lung Cancer

NCCN TAGRISSO (osimertinib) Research Grant Opportunity

The overall aim is to develop investigator initiated clinical, preclinical and correlative studies to evaluate the effectiveness of TAGRISSO (osimertinib) in the treatment of systemic or CNS EGFRm+ non-small cell lung cancer (NSCLC).
Due Dates: Jan. 10 (OSR) Ι Jan. 12 (Sponsor)
Amount & Project Period: See RFP
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFP  (You must log into the NCCN site to view these documents)

January 13 (LOI) All Ranks Non-federal Hematological Malignancies

Leukemia & Lymphoma Society
Translational Research Program

Applications proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. Application should have a clear plan for clinical translation of studies proposed and results expected.  Proposed research should be clinically directed or clinically translatable in hematologic malignancies that is intended to develop innovative approaches to treatment, diagnosis, or prevention.
Due Dates: Jan. 13 (Letter of Intent)
Applications Due:  Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Amount & Project Period: $600,000 - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Guidelines & Instructions
U01 NCI

NEW
January 13 (LOI) All Ranks Federal Clinical Assay Development

Integrating Biospecimen Science Approaches into Clinical Assay Development

This FOA will support research to investigate and mitigate challenges facing clinical assay development due to biopsy biospecimen preanalytical variability.
Due Dates: Jan. 13 (Letter of Intent)
Feb. 09 (OSR) Ι Feb. 13 (Sponsor)
Additional Due Dates:  Oct. 11, 2017
Amount & Project Period: $250,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks - A multidisciplinary research team is encouraged.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-166



NEW
January 15 Junior Faculty Non-federal Molecular Imaging

Society of Nuclear Medicine and Molecular Imaging
2017 Mitzi & William Blahd, MD Pilot Research Grant

Support for basic and clinical scientists in early stages of their career with projects that are relevant to advancing molecular imaging.
Due Dates: Jan. 12 (OSR) | Jan. 15 (Sponsor)
Amount & Project Period: $25,000 (TOTAL) - 1 year
Eligibility: Must be no more than 5 years post training (most recent training; training includes residency, MD/PhD training, professional school, graduate school, post doc, or fellowship). Must not have been PI of a peer-reviewed grant for more than $50,000 in a single calendar year.
Preference given to individuals demonstrating potential for a research career in nuclear medicine/molecular imaging and whose research focus is on translational in vivo studies including radionuclide imaging or therapy.
Must be a member of SNMMI at time of award.
Contact: Office of Sponsored Research (x6804)
Link: Mitzi & William Blahd, MD Pilot Research Grant




January 16 Junior Faculty Non-federal Pain Management

American Pain Society and Rita Allen Foundation
Rita Allen Foundation Award in Pain

Proposed research projects should be directed towards the molecular biology of pain and/or basic science topics related to the development of new analgesics for the management of pain due to terminal illness.
Due Dates: Jan. 12 (OSR) Ι Jan. 16 (Sponsor)
Amount & Project Period: $150,000 - 3 years
Eligibility: Should be in first three years of a tenure track or equivalent position;
May not have a funded R01 award while this application is under review;
Associate professors should not be applicants.
Contact: Office of Sponsored Research (x6804)
Links: Overview
Grant Guidelines
proposalCENTRAL (Submission Site)


NEW
January 18, 3:00pm (LOI) All Ranks Non-federal Gene Therapy

amfAR, The Foundation for AIDS Research
Gene therapy to cure HIV

The purpose of this RFP is to develop a gene therapy-based approach to curing HIV.  The technology to deliver gene therapy payloads requires further development and is the subject of this solicitation.  In the context of this RFP, gene therapy is defined as the targeted modification of HIV or host cell DNA or RNA.   The goal of these modifications is the permanent removal of HIV reservoirs.
Due Dates: Must request LOG-IN CREDENTIALS by 3:00pm on January 12th.
January 18, 2017, 3:00 PM (Letter of Intent)
Invited applications:  Mar. 11 (OSR) Ι Mar. 13 (Sponsor)
Amount & Project Period: $400,000 - 1 year
NOTE:  This initial one-year period of funding will be used to select research teams best suited to participate subsequently in ARCHE-GT, to be launched in 2018. 
Eligibility: Researchers with doctoral degrees, with or without documented experience in HIV research, are eligible.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFP

January 20 Junior Faculty Non-federal Digestive Cancer

American Gastroenterological Association
AGA-Caroline Craig Augustyn & Damian Augustyn Award in Digestive Cancer

Intended to supplement existing career development funding, proposals arte solicited for research relevant to the pathogenesis, prevention, diagnosis, or treatment of digestive cancer.
Due Dates: Jan. 18 (OSR) Ι Jan. 20 (Sponsor)
Amount & Project Period: $40000 - 1 year
Eligibility: Candidate must hold an NIH K series (e.g. K01, K08, K23, K99, R00) or other federal or non-federal career development award of at least four years duration with at least one year remaining on the award by July 1, 2017.
May not hold an R01 or equivalent
Contact: Office of Sponsored Research (x6804)
Link: Overview

R18 - Research Demonstration and Disseminations Projects

January 25 All Ranks Federal Safe Medication Use

Agency for Healthcare Research and Quality Advancing Patient Safety Implementation through Safe Medication Use Research

This FOA will fund investigative research demonstration projects that examine the effective implementation of processes, policies, and behaviors that support safe use of medication as well as its sustainment and dissemination.
Due Dates: Jan. 23 (OSR) Ι Jan. 25 (Sponsor)
Amount & Project Period: $1.5M (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-421
R21 NCI

January 27 (LOI) All Ranks Federal Molecular & Cellular Analysis Technologies

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Exploratory research projects focused on early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. Emphasis is on supporting development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. 
Due Dates: January 27 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Additional Due Dates: May 26; Sept. 26
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-010
R33 NCI

January 27 (LOI) All Ranks Federal Molecular/Cellular Analysis

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Research applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research.
Due Dates: January 27 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Additional Due Dates: May 26; Sept. 26
Amount & Project Period: $300,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link:  RFA-CA-17-011
R21 NCI

January 27 (LOI) All Ranks Federal Technologies - Biospecimen Science

Innovative Technologies for Cancer-Relevant Biospecimen Science

Exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care, including new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. 
Due Dates: January 27 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Additional Due Dates: May 26; Sept. 26
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-012
R33 NCI

January 27 (LOI) All Ranks Federal Biospecimen Science

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research

Exploratory research projects focused on further development and validation of emerging technologies that improve quality of samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. 
Due Dates: January 27 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Additional Due Dates: May 26; Sept. 26
Amount & Project Period: $300,000/yr. (Direct Costs) - 3 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-013
R01 NIH

Revision applications to active NIH R01 awardees

               

January 30 (LOI) See Below Federal Biomarker Assay Validation

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants

Specific focus is on adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response to treatment, as well as markers for cancer control and prevention.  Research applications may support acquisition of well-annotated specimens from NCI-supported or other clinical trials or observational cohorts/consortia for the purpose of clinical validation of the assay.
Due Dates: Jan. 30 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Addnl. Due Dates: July 11 & Oct. 27, 2017
Amount & Project Period: $150,000/yr. (Direct Costs) - Parent grant must be active when application is submitted. There must be a minimum 2 years of support remaining on parent award (not to include a no cost extension) at estimated time of award.
Eligibility: The PD(s)/PI(s) on the revision must be the PD(s)/PI(s) on the parent grant, but other PD(s)/PI(s) may be the leaders of the assay validation team.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-003


January 31 All Ranks Non-federal Pancreatic

The National Pancreas Foundation
Research Grants

Research must be in the field of pancreatic diseases. Studies intended to advance knowledge in the areas of pancreatic carcinoma, and all forms of pancreatitis would be the closest to the areas of interest of the NPF.
Due Dates: Jan. 26 (OSR) Ι Jan. 31 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview

January 31 All Ranks Non-federal Sarcoma

Sarcoma Foundation of America
Research Grants

This program provides grants to investigators interested in translational science sarcoma research The Foundation will only accept applications that focus on the following areas of research:
   Omic characterization of sarcomas and definition of novel targets
   Omic patterns of sensitivity and resistance to existing agents
   Systemic therapy combinations
   Immunotherapy
Due Dates: Jan. 27 (OSR) Ι Jan. 31 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Apply for a Grant
FAQs
proposalCENTRAL (Submission Site)


NEW
January 31 Junior Faculty Non-federal Career Development

American Thyroid Association (ATA)
ATA Call for Research Grants

Funds available to support investigator initiated research projects in the area of thyroid function and disease.  Topics may include, but are not limited to, Clinical Disorders of Thyroid Function, Thyroid Autoimmunity, Thyroid Cancer, Thyroid Hormone Effect and Metabolism, Thyroid Imaging, Thyroid Nodules and Goiter.
Due Dates: Jan. 31 (Letter of Intent)
Invited Submissions:  May, 2017
Amount & Project Period: $50,000 (Direct Costs) - 2 years
Eligibility: Must be new investigators <6 years from completion of post-doctoral fellowship and not been PI on an NIH RO1 or equiv. grant (recipients of NIH R29, R21 and KO8 awards are eligible); Postdocs are eligible if their department provides written confirmation that at time of award that applicant will have a junior faculty position;
Must be ATA member or apply for complimentary membership.
Contact: Office of Sponsored Research (x6804)
Links: Call for Research Grants Proposals Ι ATA


NEW
January 31 (LOI) Faculty Non-federal Myelodysplastic Syndromes (MDS)

Edward P. Evans Foundation
Discovery Research Grants 2017

The focus for highly innovative and novel research awards will be on transformational basic, translational or aspects of clinical research directly applicable to the etiology, pathogenesis or treatment of MDS.
Due Dates: January 31, 2017 (Letter of Intent)
Invited Proposals:  Date is TBN - Early April
Amount & Project Period: Up to $200,000 - 1 year (Renewable)
Eligibility: Must be established independent investigators w/a tenure-track or tenured appointment at Asst. Professor level (or equiv.), or higher.
Contact: Office of Sponsored Research (x6804)
Links: General Funding Information Request for Letters of Intent


February 01 (LOI) Junior Faculty Non-federal Career Development

Leukemia Research Foundation
Hollis Brownstein New Investigator Research Program  

This program allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs. Preference given to proposals that focus on leukemia, lymphoma, MDS, and multiple myeloma.
Due Dates: Feb. 01 (Letter of Intent)
Invited Applications:  Mar. 13 (OSR) Ι Mar. 15 (Sponsor)
Amount & Project Period:  $100,000 - 1 year
Eligibility: New Investigators are considered to be w/in 7 years of first independent position;
Applicants with an NIH KO8 or K23 are eligible;
See application information for additional information
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Application Instructions
U54 NCI

NEW
February 01 (LOI) All Ranks Federal Precision Medicine

PDX Development and Trial Centers (PDTCs)

Applications are sought for PDX (patient-derived xenografts) Development and Trial Centers (PDTCs) to serve as laboratory research units of the PDX Development and Trial Centers Research Network (PDXNet). The PDXNet coordinates collaborative, large-scale development and pre-clinical testing of targeted therapeutic agents in patient-derived models to advance the vision of cancer precision medicine.  The main goals for PDTCs include:
Development of new PDX models and methods for preclinical testing of single agents and drug combinations; and
Conducting studies of response of PDX models to novel therapeutic strategies using the newly established models as well as other existing well-characterized PDX models.
Due Dates: Feb. 01 (Letter of Intent)
Mar. 01 (OSR) Ι Mar. 03 (Sponsor)
Amount & Project Period: Not to exceed $800,000/yr. (Direct Costs) - 5 years (req'd.)
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-003
Companion RFA: RFA-CA-17-004, (U24 Resource-Related Research Projects - Cooperative Agreement) 
U54 NIH

NEW
February 01 (LOI) All Ranks Federal Drug Resistance/Sensitivity

Mechanisms of Cancer Drug Resistance and Sensitivity

The goal is to create a network of Drug Resistance and Sensitivity Centers (DRSCs) to develop innovative strategies to study mechanisms of tumor resistance or sensitivity to anticancer therapy.  Each DRSC should be based on 2-3 interrelated research projects. Applicants may propose collaborative arrangements (w/in 1 institution and/or with partnering institutions) to ensure all capabilities that might be necessary to fulfill the need for highly specialized multidisciplinary expertise.
Due Dates: Feb. 01 (Letter of Intent)
Mar. 01 (OSR) Ι Mar. 03 (Sponsor)
Amount & Project Period: Not to exceed $750,000/yr. (Direct Costs) 5 years (req'd.)
Eligibility: All Ranks - Note:  Given the potential for multi-disciplinary and multi-institutional teams, applicants are encouraged to take advantage of the multiple PDs/PIs option.  An individual may be designated as a PD/PI only on one DRSC application
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-009


NEW
February 05 All Ranks Federal Shared Decision Making

Agency for Healthcare Research and Quality (AHRQ)
Developing Measures of Shared Decision Making (R01)

The purpose is to invite applications to develop, test, and evaluate measures of Shared Decision Making that can be used to conduct research in clinical settings.
Due Dates: Feb. 02 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Not to exceed $1,500,000 (TOTAL) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-424
R01 NIH
NEW
February 05 All Ranks Federal See FOA

R01 Funding Opportunity Announcements with Standard Due Dates

Below is a short list of a few of the new/renewed Funding Opportunity Announcements (FOAs) where the National Cancer Institute is either the lead or is a participating institute.  Standard due dates apply.
Due Dates: Feb. 02 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link and Title: PA-13-354  Advancing the Science of Geriatric Palliative Care
 PA-17-018  Palliative Care Needs of Individuals with Rare
                     Advanced   Diseases and Their Family Caregivers
PA-17-041  Addressing the Etiology of Health Disparities and
                     Health Advantages among Immigrant Populations
PA-17-043  Addressing Health Disparities through Effective
                     Interventions among Immigrant Populations
PA-17-060  Oral Anticancer Agents: Utilization, Adherence, and
                     Health Care Delivery
Admin. Supplement NIH

NEW
February 13 See below Federal Sex/Gender Influences

Administrative Supplement for Research on Sex/Gender Influences

The purpose is to support research highlighting the impact of sex/gender influences and/or sex and gender factors in human health and illness, including basic, preclinical, clinical and behavioral studies.  Of special interest are studies relevant to understanding the significance of biological sex on cells and tissue explants; comparative studies of male and female tissues, organ systems and physiological systems; sex-based comparisons of pathophysiology, biomarkers, gene expression, clinical presentation and prevention and treatment of diseases.  Proposed research must address at least one objective from Goals 1 through 3 of the NIH Strategic Plan for Women's Health Research.
Due Dates: Feb. 09 (OSR) Ι Feb. 13 (Sponsor)
Amount & Project Period: Max. $65,000 (Direct Costs) – 1 year
Must be w/in currently approved project period for existing parent grant and parent must have at least 18 months of active grant support remaining from the administrative supplement application due date.  
Eligibility: Individual(s) must hold an active grant or cooperative agreement, and research proposed in the supplement must be accomplished within the competitive segment of active award.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-078
R01 NIH

NEW
February 07 All Ranks Federal Cancer and Behavior

Cancer-related Behavioral Research through Integrating Existing Data

To encourage applications that incorporate Integrative Data Analysis (IDA) methods to study behavioral risk factors for cancer, including tobacco use, sedentary behavior, poor weight management, and lack of medical adherence to screening and vaccine uptake.  Importantly, applicants should use existing data sources rather than collect new data.  Creating harmonized measures, developing culturally sensitive measures, replicating results and cross-study comparisons will be encouraged.
Due Dates: Feb. 05 (OSR) Ι Feb. 07 (Sponsor)
Additional Due Date:  June 07, 2017
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-256
Companion FOA: PAR-16-255 (R21)
K-Awards NCI

NEW
February 13 See FOA Federal Career Development

NCI  K-Awards Summary

 
Due Dates: Feb. 09 (OSR) Ι Feb. 13 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Up to $100,000/year salary
$30,000 to 50,000/yr.  Research Development Costs, depending on award mechanism.
Duration of award is 3-5 years depending on mechanism.
Awards are not renewable.
Contact: Office of Sponsored Research (x6804)
For detailed information, including eligibility and funding on the K-mechanisms listed below, please see Cancer Training at NCI or the Funding Opportunity announcement listed with each mechanism.  

NCI K07 Award - Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (PAR-16-284) NOTE:  The last due date to submit a new application and to also be able to resubmit that application if it does not receive a fundable score will be February 13, 2017, and for any new/resubmission K07 applications the final dates will be October 12/November 13, 2017.

NCI K08 Award - Mentored Clinical Scientist Research Career Development Award (PA-16-191)

NCI K22 Award - The Transition Career Development Award (PAR-16-293)
                               The Transition Career Development Award to Promote Diversity (PAR-17-069)

NCI K23 Award - Mentored Patient-Oriented Research Career Development Award (PA-16-198)

NCI K99 Award - The Pathway to Independence Award – (PA-16-193)  
U24 NIH
Common Fund Initiative

NEW
February 14 (LOI) All Ranks Federal The Druggable Genome

Data and Resource Generation Centers for Illuminating the Druggable Genome

The overarching goal of this FOA and its companion announcements is to generate a research consortium to facilitate the unveiling of the functions of selected understudied proteins in the Druggable Genome using experimental and informatics approaches.   This FOA calls for utilization of ensembles of scalable technology platforms to characterize functions of understudied non-olfactory G protein-coupled receptors (GPCRs), protein kinases, and ion channels at molecular and cellular levels in medium- to high-throughput fashion, rather than by a "one at a time" approach.
Due Dates: Feb. 14 (Letter of Intent)
Applications due:  Mar. 10 (OSR) Ι Mar. 14 (Sponsor)
Amount & Project Period: Max. $1.6M/yr. (Direct Costs) - 6 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-16-026
Companion RFAs: RFA-RM-16-024 U24 - Knowledge Management Center for Illuminating the Druggable Genome
RFA-RM-16-025 U24 - Resource Dissemination and Outreach Center for Illuminating the Druggable Genome

NEW
February 14 (LOI) All Ranks Federal PCOR

Patient Centered Outcomes Research Institute
Upcoming Opportunities - Cycle 1 2017

 
Due Dates: February 14 (Letter of Intent)
Applications Due:  May 15 (OSR) Ι May 17 (Sponsor)
Additional Due Dates: Cycle 2 - 2017:  Jul. 25 (Letter of Intent)
                                        Cycle 3 - 2017:  Oct. 31 (Letter of Intent)
Amount & Project Period: See Specific Announcement
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Primary Link: Funding Opportunities
Addressing Disparities Funds & manages projects designed to reduce or eliminate health disparities, paying special attention to care delivery and outcomes. Disparities in health and healthcare quality and outcomes can be based on various factors, such as race, ethnicity, or socioeconomic status, which contribute to poor quality of care and overall health outcomes for specific populations.
  Assessment of Prevention, Diagnosis, and Treatment Options Comparative effectiveness research designed to provide information that would inform critical decisions that face patients and caregivers, clinicians, policy makers, and healthcare system leaders.
  Communication and Dissemination Research Focuses on comparing approaches to providing CER information, empowering people to ask for and use the information, and supporting shared decision making between patients and their providers
    Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes Pragmatic clinical trials (PCTs), large simple trials (LSTs), or large-scale observational studies that compare two or more alternatives for addressing prevention, diagnosis, treatment, or management of a disease or symptom; improving healthcare system-level approaches to managing care; or eliminating health or healthcare disparities.


NEW
February 15 Postdocs Non-federal Career Development

Howard Hughes Medical Institute
Hanna H. Gray Fellows Program

This program seeks to increase diversity in the biomedical research community by recruitment and retention of individuals from groups underrepresented in the life sciences.
Due Dates: Feb. 13 (OSR) Ι Feb. 15, 3:00, pm ET (Sponsor)
Amount & Project Period: Fellowship Phase:        $160,000 - 2 years
Faculty Phase:              $270,000/yr. - 4 years (To transition to faculty phase, Fellows must obtain a faculty position in the tenure-track (or equiv.) at a U.S. (including Puerto Rico) research institution with a doctoral-level graduate program in their area of interest.)
Eligibility: The program is open to individuals who are from gender, racial, ethnic, and other groups under-represented in the life sciences, including those from disadvantaged backgrounds.
Applicants must have a PhD and/or MD(or equiv.) by start of the grant term.
Applicants can have no more than 12 months of postdoctoral research experience at application due date.
The program is open to applicants of any citizenship or nationality who have been accepted to join a laboratory as a postdoctoral fellow at a research institution located in the U.S. (including Puerto Rico).
Required to devote at least 75% of  total effort to research.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι 2017 Program Announcement


NEW
February 16 All Ranks Federal Heath & IT

Agency for Healthcare Research and Quality
Exploratory and Developmental Grant to Improve Health Care Quality through Health Information Technology (IT) (R21)

The purpose of this FOA is to fund exploratory and developmental research that will contribute to the evidence base of how health IT improves health care quality.  This FOA supports the use of a wide variety of research designs in order to generate information regarding the design and development, implementation, use, or impact of health IT on quality. The 5 research areas of interest are: Design; Implementation; Use; Impact on Outcomes; and Measurement.
Due Dates: Feb. 14 (OSR) Ι Feb 16 (Sponsor)
Additional Due Dates:  Standard Due Dates
Amount & Project Period: $300,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Note:  Only 1 PD/PI may be designated.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-14-001
R21 NCI

NEW
February 16 All Ranks Federal Oral

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery

The purpose is to encourage applications to: (1) assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; (2) identify structural, systemic, and psychosocial barriers to adherence; and (3) develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.
Due Dates: Feb. 14 (OSR) Ι Feb. 16 (Sponsor)                                        Additional Due Dates:  Standard dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-061
Companion FOA: PA-17-060 (R01)
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org